Nothing Special   »   [go: up one dir, main page]

MA51432A - Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires - Google Patents

Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires

Info

Publication number
MA51432A
MA51432A MA051432A MA51432A MA51432A MA 51432 A MA51432 A MA 51432A MA 051432 A MA051432 A MA 051432A MA 51432 A MA51432 A MA 51432A MA 51432 A MA51432 A MA 51432A
Authority
MA
Morocco
Prior art keywords
intermediaries
pyrimidine
amino
preparation
Prior art date
Application number
MA051432A
Other languages
English (en)
Inventor
Tohru Fukuyama
Kevin Lu
Bradley MORGAN
David Morgans
Matthew Peterson
Original Assignee
Cytokinetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc
Publication of MA51432A publication Critical patent/MA51432A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/20Preparation of carboxylic acid nitriles by dehydration of carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/45Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA051432A 2017-12-26 2018-12-26 Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires MA51432A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762610302P 2017-12-26 2017-12-26

Publications (1)

Publication Number Publication Date
MA51432A true MA51432A (fr) 2020-11-04

Family

ID=67068143

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051432A MA51432A (fr) 2017-12-26 2018-12-26 Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires

Country Status (15)

Country Link
US (1) US11142516B2 (fr)
EP (1) EP3732166A4 (fr)
JP (1) JP7209726B2 (fr)
KR (1) KR20200109314A (fr)
CN (1) CN112236415B (fr)
AU (1) AU2018397684B2 (fr)
BR (1) BR112020013020A2 (fr)
CA (1) CA3087051A1 (fr)
EA (1) EA202091588A1 (fr)
IL (1) IL275655B2 (fr)
MA (1) MA51432A (fr)
MX (1) MX2020006704A (fr)
PH (1) PH12020550983A1 (fr)
SG (1) SG11202006085PA (fr)
WO (1) WO2019133605A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111848423B (zh) * 2019-04-30 2022-10-14 尚科生物医药(上海)有限公司 3-氧代环丁基氨基甲酸叔丁酯的制备方法
MA56396A (fr) * 2019-06-27 2022-05-04 Cytokinetics Inc Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide
WO2024064745A1 (fr) 2022-09-21 2024-03-28 Cytokinetics, Incorporated Synthèse de reldesemtiv

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2567851A1 (fr) * 2004-05-21 2006-01-05 Merck & Co., Inc. Modulateurs heterocycliques et carbocycliques d'amino cyclopentyle de l'activite du recepteur de la chimiokine
MX2009012117A (es) * 2007-05-09 2009-11-23 Pfizer Composiciones y derivados heterociclicos sustituidos y su uso farmaceutico como antibacterianos.
AR081331A1 (es) * 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
WO2011133920A1 (fr) 2010-04-23 2011-10-27 Cytokinetics, Inc. Aminopyridines et aminotriazines, leurs compositions et leurs procédés d'utilisation
ES2750751T3 (es) * 2014-09-09 2020-03-27 Astellas Pharma Inc Composición farmacéutica novedosa para la prevención y/o el tratamiento de la incontinencia urinaria

Also Published As

Publication number Publication date
KR20200109314A (ko) 2020-09-22
BR112020013020A2 (pt) 2020-11-24
JP2021508702A (ja) 2021-03-11
EP3732166A4 (fr) 2021-09-01
EA202091588A1 (ru) 2021-01-18
AU2018397684A1 (en) 2020-07-16
JP7209726B2 (ja) 2023-01-20
US20210061786A1 (en) 2021-03-04
CA3087051A1 (fr) 2019-07-04
MX2020006704A (es) 2020-09-14
IL275655A (en) 2020-08-31
CN112236415A (zh) 2021-01-15
IL275655B2 (en) 2023-07-01
US11142516B2 (en) 2021-10-12
AU2018397684B2 (en) 2023-09-07
WO2019133605A1 (fr) 2019-07-04
EP3732166A1 (fr) 2020-11-04
IL275655B1 (en) 2023-03-01
CN112236415B (zh) 2023-11-14
SG11202006085PA (en) 2020-07-29
PH12020550983A1 (en) 2021-03-22

Similar Documents

Publication Publication Date Title
MA52665A (fr) Procédé d'amélioration de l'expression de l'hémoglobine foetale
MA45539A (fr) Dihydropyranopyrimidines pour le traitement d'infections virales
MD3827845T2 (ro) Formulări subcutanate de anticorpi anti-CD38 și utilizări ale acestora
MA55629A (fr) Compositions d'anticorps pour le traitement de tumeurs
WO2015153889A3 (fr) Substances et procédés pour le traitement d'une infection virale latente
MA51815A (fr) Méthodes de traitement ou de prévention de migraines avec anticorps contra le receptor de cgrp
MA43835A (fr) Procédé de préparation de lieurs de médicaments pégylés et leurs intermédiaires
MA47719A (fr) Esketamine pour le traitement de la dépression
TW201613880A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
BR112017007012A2 (pt) compostos anti-tnf
DK3668509T3 (da) Fremgangsmåde til behandling af amyotrofisk lateralsklerose med pridopidin
MA45155A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
MA53370A (fr) Procédé et intermédiaires pour la préparation de bilastine
MA42657A (fr) Anticorps inhibiteurs anti-pcsk9 destinés au traitement des patients atteints d'hyperlipidémie subissant une aphérèse de lipoprotéines
MA50169A (fr) Procédé de production d'un électrocatalyseur
MA47511A (fr) Procédés de préparation d'ag-10, de ses intermédiaires et de sels correspondants
MA51432A (fr) Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires
ZA201900506B (en) Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamides
MA49700A (fr) Procédé amélioré pour la préparation de dérivés d'aminopyrimidine
MA42423A (fr) Procédé de préparation d'un revêtement
EP3500293A4 (fr) Méthodes de traitement de la maladie de crohn avec un anticorps anti-nkg2d
EP3261446A4 (fr) Méthodes et compositions permettant le traitement ou la prévention de la maladie de parkinson
MA50124A (fr) Procédé de préparation de tubulysines et d'intermédiaires de celles-ci
MA46431A (fr) Composés et procédés pour réduire l'expression de tau
MA39411A (fr) Synthèse de l'énantiomère de la progestérone et ses intermédiaires